Announcement
18 Jul 2022
In July 2022, the EIB provided financing worth EUR 50 million (USD 51 million) to Laboratorios Farmaceuticos Rovi SA.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
18 Jul 2022
Revocation date:
No revocation date
Updated: 18 Jul 2022
State loan
In force
On 18 July 2022, the European Investment Bank (EIB) and Laboratorios Farmaceuticos Rovi SA signed a loan agreement worth EUR 50 million (approx. USD 51 million) for the project 'Rovi Pharma Technology...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.